MESOBLAST LTD (MESO)
Latest MESO Insider Trades
Gregory George - DirectorOpen-market purchase$5.68M- Gregory George - DirectorOpen-market purchase$1.27M
About MESOBLAST LTD (MESO)
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
- 108
- 2009
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 650,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
MESO Insider Transactions (Form 4)
313 Form 4 filings on record, the earliest from Apr 10, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 James Michael Obrien - Officer | Grant or award | Option (Right to buy) |
MESO Insider Trading - FAQ
What is the latest insider trade for MESO?
MESOBLAST LTD (MESO) had 1 insider filing in the last 90 days, with the most recent on 2026-07-10. The full record for MESO runs to 3 Form 4 filings, the earliest from 2026-04-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying MESO stock?
No insider purchases of MESO were filed in the last 90 days. 30 purchases are on record for this company.
How many insiders are selling MESO stock?
No insider sales of MESO were filed in the last 90 days.
Where can I see MESO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks MESO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow MESO insider buys?
Create a free InsiderAlpha account and press Watch on this page to add MESO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
3Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - James Michael Obrien view on EDGAR
- - Gregory George view on EDGAR
- - Gregory George view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where MESO's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track MESO insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
